West Pharmaceutical Services (WST) Short term Debt (2009 - 2023)

West Pharmaceutical Services has disclosed Short term Debt across 15 years of filings, most recently posting $2.2 million for Q3 2023.

• In Q3 2023, Short term Debt changed 0.0% year-over-year to $2.2 million; the TTM figure through Sep 2023 stood at $2.2 million (changed 0.0% YoY), while the FY2021 annual figure was $44.2 million, up 1821.74% from the prior year.
• Short term Debt came in at $2.2 million for Q3 2023 at West Pharmaceutical Services, roughly flat from $2.2 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $44.2 million in Q3 2021 to a low of $2.2 million in Q1 2022.
• Average Short term Debt over 5 years is $7.8 million, with a median of $2.3 million recorded in 2019.
• Year-over-year, Short term Debt surged 2200.0% in 2019 and plunged 95.02% in 2022.
• Over 5 years, Short term Debt stood at $2.3 million in 2019, then changed by 0.0% to $2.3 million in 2020, then soared by 1821.74% to $44.2 million in 2021, then sank by 95.02% to $2.2 million in 2022, then changed by 0.0% to $2.2 million in 2023.
• Per Business Quant data, the three most recent Short term Debt figures were $2.2 million in Q3 2023, $2.2 million in Q2 2023, and $2.2 million in Q1 2023.